A detailed history of Wellington Management Group LLP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 34,994 shares of SWTX stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,994
Previous 33,141 5.59%
Holding current value
$1.31 Million
Previous $1.25 Million 10.18%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.04 - $42.76 $59,370 - $79,234
1,853 Added 5.59%
34,994 $1.12 Million
Q2 2024

Aug 13, 2024

BUY
$36.06 - $47.62 $183,437 - $242,242
5,087 Added 18.13%
33,141 $1.25 Million
Q1 2024

May 15, 2024

BUY
$36.5 - $52.5 $1.02 Million - $1.47 Million
28,054 New
28,054 $1.38 Million
Q4 2023

Feb 12, 2024

BUY
$18.94 - $37.24 $400,902 - $788,259
21,167 New
21,167 $772,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.34B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.